Evaluation of radiation effects against C6 glioma in combination with vaccinia virus-p53 gene therapy

International Journal of Oncology

Volumn 13, Issue 5, 1998, Pages 1093-1098

  Gridley, Daila S ^a,b   Andres, Melba L ^a   Li, Jun ^a   Timiryasova, Tatyana ^a   Chen, Bing ^a   Fodor, Istvan ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOMA LINDA UNIVERSITY   (United States)

Author keywords

Gene therapy; Glioma; p53; Radiation; Vaccinia virus

Indexed keywords

PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INCIDENCE; CANCER RADIOTHERAPY; CLONING VECTOR; CONTROLLED STUDY; GENE THERAPY; GLIOMA; LEUKOCYTE COUNT; LYMPHOCYTE TRANSFORMATION; MALE; MULTIMODALITY CANCER THERAPY; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIVITY; SPLEEN WEIGHT; TREATMENT OUTCOME; TUMOR VOLUME; VACCINIA VIRUS; VIRUS STRAIN;

EID: 0031733175     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.13.5.1093     Document Type: Article

References (33)

1. Constinc LS, Konski A and Ekholm S: Adverse effects of brain irradiation correlated with MR and CT imaging. Int J Radiat Oncol Biol Phys 15: 319-325, 1988.
2. Leibel S and Sheline G: Tolerance of the central and peripheral nervous system to therapeutic irradiation. Adv Radiat 12: 257-288, 1985.
3. Salcman M and Kaplan R: Intracranial tumors in adults. In: Comprehensive Textbook of Oncology. Moosa AR, Schimpff SC and Robson MC (eds). Williams & Wilkins, Baltimore, MD, pp1339-1352, 1991.
4. Hellman S and Weichselbaum RR: Radiation oncology and the new biology. Cancer J Sci Amer 1: 174-179, 1995.
5. Kastan MB, Oneykwere D, Sidransky D, Vogelstein B and Craig R: Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51: 6304-6311, 1991.
6. Lowe SW, Schmitt EM, Smith SW, Osborne BA and Jack T: p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847-852, 1993.
7. Rupnow BA, Alarcon RM, Glaccia AJ and Knox SJ: p53 mediates apoptosis induced by c-Myc activation in hypoxic or gamma irradiated fibroblasts. Cell Death Differ 5: 141-147, 1998.
8. Bristow RG, Benchimol S and Hill RP: The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy. Radiother Oncol 40: 197-223, 1996.
9. Greenblatt MS, Bennett WP, Hollstein M and Harris CC: Mutations in the p53 tumor suppressor gene: clues to cancer ctioloey and molecular pathocenesis. Cancer Res 54: 4855-4878, 1994.
10. Hollstein M, Sidransky D, Vogelstein B and Harris CC: p53 mutations in human cancers. Science 253: 49-53, 1991.
11. Jaros E, Perry R, Adam L, Kelly PJ, Crawford PJ, Kalbag RM, Mendelow AD, Sengup RP and Pearson AD: Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours. Br J Cancer 66: 373-385, 1992.
12. Sidransky D, Mikkelsen T, Schwechheimer K, Rosenblum M, Cavance W and Vogelstein B: Clonal expansion of p53 mutant cells is associated with brain tumour prosression. Nature 355: 846-857, 1992.
13. Yount GL, Haas-Kogan DA, Vidair CA, Haas M, Dewey WC and Israel MA: Cell cycle synchrony unmasks the influence of p53 function on radiosensitivity of human clioblastoma cells. Cancer Res 56: 500-506, 1996.
14. Bracey TS, Williams AC and Paraskeva C: Inhibition of radiation-induced G2 delay potentiates cell death by apoptosis and/or the induction of giant cells in colorectal tumor cells with disrupted p53 function. Clin Cancer Res 3: 1371-1381, 1997.
15. Fan SJ, El-Deiry WS, Bac I, Freeman J, Jondle D, Bhatia K, Fornace AJ Jr, Magrath I, Kohn KW and O'Connor PM: p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Cancer Res 54: 5824-5830, 1994.
16. Lee JM and Bernstein A: p53 mutations increase resistance to ionizing radiation. Proc Natl Acad Sci USA 90: 5742-5746, 1993.
17. Buchsbaum DJ, Raben D, Stackhouse MA, Khazaeli MB, Rogers BE, Rosenfeld ME, Liu T and Curiel DT: Approaches to enhance cancer radiotherapy employing gene transfer methods (review). Gene Ther 3: 1042-1068, 1996.
18. Gallardo D, Drazan KE and McBride WH: Adenovirus-based transfer of wild-type p53 gene increases ovarian tumor radiosensitivity. Cancer Res 56: 4891-4893, 1996.
19. Nielsen LL, Lipari P, Dell J, Gurnami M and Hajian G: Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer. Clin Cancer Res 4: 835-846, 1998.
20. Nielsen LL and Maneval D: p53 tumor suppressor gene therapy for cancer. Cancer Gene Ther 5: 52-63, 1998.
21. Ram Z, Culver KW, Walbridge Blaese RM and Oldfield EH: In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res 53: 83-88, 1993.
22. Mackett M and Smith GL: Vaccinia virus expression vectors (review). J Gen Virol 67: 2067-2082, 1986.
23. Moss B: Genetically engineered poxvirus for recombinant gene expression, vaccination and safety. Proc Natl Acad Sci USA 93: 11341-11348, 1996.
24. Timiryasova T, Andres ML, Li J, Gridley DS and Fodor I: Inhibition of C6 glioblastoma tumor growth in nude mice by vaccinia virus and its recombinant derivative expressing tumor suppressor p53. Cancer Gene Ther 4: S20, 1997.
25. Timiryasova T, Li J, Chong D, Langridge WHR, Gridley DS and Fodor I: Vaccinia virus mediated in vitro and ex vivo delivery of the p53 gene into glioma cells for therapy of glial tumors. Cancer Gene Ther 4: S20, 1997.
26. Benda P, Lightfoot J, Sato G, Levine L and Sweet W: Differentiated rat glial cell strain in tissue culture. Science 161: 370-371, 1968.
27. Auer R, Del Maestro RF and Andersen R: A simple and reproducible experimental in vivo glioma model. Can J Neurol 8: 325-331, 1981.
28. Stewart PA, Hayakawa K, Hayakawa E, Farrell CL and Del Maestro RF: A quantitative study of blood brain barrier permeability ultrastructure in a new glioma model. Acta Neuropathol 67: 96-102, 1985.
29. Baker SJ, Markowitz S, Fearon ER, Willson JKV and Vogelstcin B: Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249: 912-915, 1990.
30. Matinez-Pomares L, Thompson JP and Moyer RW: Mapping and investigation of the role in pathogenesis of the major unique secreted 35-kDa protein of rabbitpox virus. Virology 206: 591-600, 1995.
31. Lathe R, Kieny MP, Gerlinger P, Clertant P, Guizani I, Cuzini F and Chambon P: Tumour prevention and rejection with recombinant vaccinia. Nature 326: 878-880, 1987.
32. Gridley DS, Archambeau JO, Andres ML, Mao XW and Slater JM: Tumor necrosis factor-α enhances the anti-tumor effects of radiation against glioma xenografts. Oncol Res 9: 217-227, 1997.
33. Sado T, Kamisaku H, Ikarashi Y and Kubo E: Immediate and long-term effects of radiation on the immune system of specific-pathogen-free mice. Int J Radiat Biol 53: 177-187, 1988.